Both Sides of the Table

JANUARY 10, 2021

If you’re not able to identify your bad choices and develop a plan you’re never going to fix them. I later switched to MyFitnessPal because after I sorted out the psychology it was easier to log what I was eating and keep a daily food journal. I literally developed self talk. You manage what you measure. Hit the number, Mark.

Coach 538

Coach Startup Guide Journal 538

SoCal CTO

NOVEMBER 5, 2009

At Pepperdine, I co-founded the Journal of Business, Entrepreneurship & the Law -- only the fourth scholarly journal in the history of the Pepperdine School of Law. Not only do our business clients turn to us for lawsuits, but they also ask us to create efficient processes and develop their brands. But if I had to pick (ie.

Startup 150

Startup SEO Pepperdine Blogging 150

InfoChachkie

JUNE 3, 2013

Yet, without realizing it, John and Kyle had begun to build a community of virtual stakeholders who eventually developed an emotional bond with the company. blogging, in a sense. If we had a blogging platform then, we would have been blogging. If we had a blogging platform then, we would have been blogging.

Newsletter 233

Newsletter Startup Entrepreneur Writing 233

Both Sides of the Table

OCTOBER 26, 2014

You help them on stories, act as a source, develop real relationships, read their stories and eventually when you have news they’re more willing to have a conversation. And you need somebody who is committed to keeping up your presence in blogs, social media and other online forums. It’s a continual process. Just don’t spam people.

Press 319

Press Startup Writing Training 319

InfoChachkie

JUNE 3, 2013

Yet, without realizing it, John and Kyle had begun to build a community of virtual stakeholders who eventually developed an emotional bond with the company. blogging, in a sense. If we had a blogging platform then, we would have been blogging. If we had a blogging platform then, we would have been blogging.

Newsletter 133

Newsletter Startup Entrepreneur Writing 133

Xconomy

AUGUST 16, 2016

A recent Wall Street Journal article that raised the possibility of Biogen as the target of another huge pharma buyout cited the lack of productivity as a major driver of M&A in the pharmaceutical industry. The authors made the point that, given the size of companies today, a single garden-variety blockbuster hardly moves the needle.

Product 40

Product Journal Venture Capital Demand 40

Both Sides of the Table

NOVEMBER 29, 2009

Our call recovered and we spent the rest of the time talking about the development of their management team and their product. But it got me thinking about how often entrepreneurs overplay their PR so I thought I’d try to offer some advice and how to play PR with VCs (or more broadly with customers or business development partners).

Venture Capital 291

Venture Capital Press News Startup 291

Tech Zulu Event

NOVEMBER 20, 2011

Maneesh has more than nine years of product development and operational experience in the high tech industry. At Broadcom, he was instrumental and led efforts in the development and evolution of the cable, satellite, and television chip sets. Maneesh has published papers in several technical journals and is the holder of three U.S.

Orange County 106

Orange County Miramar Startup Tech Coast Angels 106

SoCal CTO

MAY 15, 2009

Formerly, he was Managing Director of both Product Management and of Business Development at Los Angeles Times Interactive. Formerly, he was Managing Director of both Product Management and of Business Development at Los Angeles Times Interactive. a social networking site for families), where the Yammer technology was developed.

Social Network 150

Social Network Networking Yammer CTO Hire 150

Both Sides of the Table

JUNE 27, 2011

Nobody likes to hear you say, “we can’t tell you anything we’re in stealth mode&# so develop some generic talking points that don’t give anything away when you’re asked what you do. Market to Your Target Audience – I’ve seen a lot of startups who like to write blog posts on life as an entrepreneur.

Marketing 380

Marketing Startup Press Technical Advisors 380

Xconomy

JULY 26, 2016

Ostendo declined my request to talk with CEO Hussein El-Ghoroury about the new funding and about the virtual reality display technology the company has been developing for over a decade. The Journal also reported at the time that Ostendo had raised $90 million from venture capital firms and Pieter Thiel, the investor and PayPal co-founder.

Technology 40

Technology Venture Capital Beverly Hills Funding 40

Xconomy

SEPTEMBER 27, 2016

Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. Fortis is licensing the technology behind the drug program from the University of California, San Francisco, where it was developed in the lab of Bin Liu. 9/27/16, 2:09 p.m.

Avalon 40

Avalon Funding Startup San Diego 40

Xconomy

SEPTEMBER 2, 2016

—Cambridge, MA-based messenger RNA drug developer Moderna Therapeutics is raising another huge financing round, according to an SEC filing. —Cambridge-based Biogen (NASDAQ: BIIB ) published the results of an early stage study of closely watched Alzheimer’s disease drug aducanumab in the journal Nature.

News 57

News San Diego Journal Technical Review 57

Xconomy

AUGUST 17, 2016

The study has not been published in a peer-reviewed journal, but Histogen CEO Gail Naughton has presented them at the World Congress for Hair Research and the 2016 Stem Cell Summit. Histogen said it plans to negotiate a license and supply agreement for the development and commercialization of HSC in China.

Invest 40

Invest San Diego Journal Technical Review 40

Frank Addante

DECEMBER 5, 2006

About Frank Addante > (from the Silicon Valley Business Journal) Twitter Updates follow me on Twitter Blog Archive ► 2010 (2) ► June (1) Part II: Optimized for Profitability ► February (1) Get Out of the Office! Under Process, Over Deliver So, you need to develop a product? ► October (1) New Video!

Outsource Development 40

Outsource Development Develop Development Product 40

Xconomy

SEPTEMBER 7, 2016

Retrophin , the drug developer founded by controversial former biotech executive Martin Shkreli, has posted positive results from a midstage study for its treatment for a rare kidney disease. The company plans to present detailed results at an upcoming medical meeting or in a peer-reviewed journal, it said in a statement.

San Diego 40

San Diego Pricing Study Journal 40

Frank Addante

JANUARY 23, 2007

About Frank Addante > (from the Silicon Valley Business Journal) Twitter Updates follow me on Twitter Blog Archive ► 2010 (2) ► June (1) Part II: Optimized for Profitability ► February (1) Get Out of the Office! Under Process, Over Deliver So, you need to develop a product? So, you need to develop a product?

Outsource Development 40

Outsource Development Develop Development Product 40

Xconomy

OCTOBER 7, 2016

. —Meanwhile, in the wake of the Mylan hearings, the Wall Street Journal this week was the latest outlet to record the animosity between drugmakers and pharmacy benefit managers , the middlemen who buy drugs in bulk for large employers and other insurance payers. KENDALL SQUARE UPS AND DOWNS. CLINICAL NEWS.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Tech Zulu Event

SEPTEMBER 23, 2010

Technology and IP law are at the forefront of the movie, and themes include common issues in startups regarding cash flow, IP rights, tech development, product design and distribution of equity. Christina blogs in the Technology section of The Huffington Post [ [link] ]. Christina holds a B.A. from the University of San Francisco.

IP 81

IP Social Network Technical Review Networking 81

Tech Zulu Event

JANUARY 21, 2013

The skilled developer “had a certain logic in his brain and the world didn’t necessarily fit in with that logic and that was sometimes difficult.”. million articles and documents from JSTOR (Journal Storage), a subscription-only service that distributes scientific and literary journals. Young Swartz. Knowledge is Power.

Journal 86

Journal Blogging RSS Report 86

Xconomy

APRIL 20, 2017

San Antonio — George Perry, a scientist at the University of Texas at San Antonio, has long proposed that drug developers and researchers need to look earlier into the roots of Alzheimer’s disease. A potential discovery that targets the early development of the disease—in.

Study 68

Study Research Develop Development 68

Xconomy

AUGUST 26, 2016

Its latest hike has brought the two-pack of injectors to more than $600, according to the Wall Street Journal. —South San Francisco, CA-based Denali Therapeutics, with ambitions to develop drugs for several neurodegenerative diseases, bagged $130 million in a Series B and unveiled a series of deals. Morgan party.

Pricing 40

Pricing Thousand Oaks Startup Research 40

Frank Addante

MAY 20, 2007

About Frank Addante > (from the Silicon Valley Business Journal) Twitter Updates follow me on Twitter Blog Archive ► 2010 (2) ► June (1) Part II: Optimized for Profitability ► February (1) Get Out of the Office! Under Process, Over Deliver So, you need to develop a product? ► October (1) New Video!

Entrepreneur 40

Entrepreneur Blogging Startup Venture Capital 40

Xconomy

JULY 8, 2016

British medical journal The Lancet published a study , funded by the Bill and Melinda Gates Foundation, that showed viral hepatitis has become the seventh leading cause of death globally, up from tenth in 1990. . The two companies will work together to develop a new cystic fibrosis treatment.

Pricing 52

Pricing News Journal Startup 52

Xconomy

AUGUST 12, 2016

—Indianapolis-based Eli Lilly (NYSE: LLY ) said that a breast cancer drug it’s been developing called abemaciclib didn’t meet a predetermined interim efficacy bar in a Phase 3 trial. Celgene remains an Acetylon investor, however, and the two are testing drugs together in a variety of trials. Its financials were posted here.

Google 40

Google Technical Review News Research 40

SoCal Delicious

OCTOBER 8, 2012

Professor Journal. Student Journal. Developments Blog. In March of last year, Matt Jacobson, head of market development at Facebook, paid $10.9 Mark Holtzman for The Wall Street Journal. Mark Holtzman for The Wall Street Journal). MarketWatch. MarketWatch. AllThingsDigital. AllThingsDigital.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44

Xconomy

JUNE 30, 2016

A key scientist involved in integrin research, Harvard University immunologist Tim Springer, is spinning out a biotech startup to develop a new generation of integrin-blocking drugs—pills instead of antibody-based injections—that he says will benefit from “a complete understanding” of these complex molecules.

Startup 40

Startup Invest Journal Research 40

Tech Zulu Event

MAY 10, 2012

Gianelle Veis , manager of prize development at X PRIZE Foundation. He works as a biophysicist at Stanford University, as Managing Editor of the Stanford Journal of Law, Science and Policy, and is a resident of the infamous Langton Labs intentional community in San Francisco. and the Chuck E Cheese’s Pizza-Time Theater chain.

Technical Advisors 89

Technical Advisors Design Education Study 89

Xconomy

AUGUST 19, 2016

Meanwhile, the latest study reporting that the drugs’ $14,000-a-year list price isn’t cost effective, published this week in the Journal of the American Medical Association , has the drugs’ owners, Amgen (NASDAQ: AMGN ) and Regeneron Pharmaceuticals (NASDAQ: REGN ), up in arms.

Technical Review 40

Technical Review Patents .Net Study 40

Tech Zulu Event

FEBRUARY 21, 2014

It’s been a short, but action packed few months since we were introduced to The Immunity Project ‘s goal to “develop a free vaccine for HIV/AIDS” The organization’s aptly named Twitter handle is @hackHIV and they’re the second nonprofit organization ever to be backed by Bay Area Incubator, Y-Combinator (YC).

Artificial Inteligence 110

Artificial Inteligence AMA Organization Research 110

Xconomy

OCTOBER 28, 2016

—Two Vertex rivals touted early-stage data at the NACFC conference: Belgium-based Galapagos , which is developing its own triple combination regimen, and Netherlands-based ProQr Therapeutics (NASDAQ: PRQR ), which is advancing an RNA-based CF drug sprayed into the lungs. THIS WEEK IN DRUG PRICING…. AND DUCHENNE. billion last year.

Pricing 40

Pricing Conference News Study 40

Xconomy

APRIL 20, 2018

While pembrolizumab notched the headline-grabbing data, others are also working to develop options for various subsets of patients. Merck showed that its immunotherapy pembrolizumab (Keytruda) might become a common option for many patients newly diagnosed with advanced lung cancer, but the bigger picture is that the field is moving fast.

Pricing 52

Pricing News Report Develop 52

Xconomy

MARCH 23, 2018

The FDA continued its campaign against cigarettes , while the Centers for Medicare & Medicaid Services (CMS) gave a much-needed boost to the developers of cancer diagnostics. We’ll start this week’s roundup with several stories from Washington, D.C. that could have a lasting effect on public health.

News 52

News Services Help Develop 52

Xconomy

OCTOBER 11, 2016

—Among the three developers of CAR-T cell therapies pushing toward the field’s first approval, Kite Pharma (NASDAQ: KITE ) was the sole presenter at ESMO. The company released detailed data at ESMO and published the results in the New England Journal of Medicine. T CELL TIDBITS.

News 40

News Study Report Santa Monica 40

Frank Addante

MAY 3, 2006

About Frank Addante > (from the Silicon Valley Business Journal) Twitter Updates follow me on Twitter Blog Archive ► 2010 (2) ► June (1) Part II: Optimized for Profitability ► February (1) Get Out of the Office! Under Process, Over Deliver So, you need to develop a product? ► October (1) New Video!

Startup 40

Startup Blogging Venture Capital Web 2.0 40

Xconomy

NOVEMBER 4, 2016

The firms will sell the data, stripped of patient identities, to drug companies looking for insights as they develop new cancer drugs or plan clinical trials. —Boulder, CO-based Miragen Therapeutics will go public via a reverse merger with diagnostics developer Signal Genetics (NASDAQ: SGNL ).

Research 40

Research Report Pricing Journal 40

SoCal Delicious

JANUARY 15, 2010

Shortcut: sebastian-x.com Blog About Blogroll Links How to cleverly integrate your own URI shortener Posted on 30 December, 2009 This pamphlet is somewhat geeky. For example when you operate a WordPress blog, you could code nearly everthing below in your 404 page (consider alternatives ). For example Yahoo truncates the trailing slash.

SEO 37

SEO IP PHP Blogging 37